The cytosolic sensor STING is required for intestinal homeostasis and control of inflammation

Mucosal Immunology

Volumn 11, Issue 3, 2018, Pages 820-834

  Canesso, M C C ^a   Lemos, L ^a   Neves, T C ^a   Marim, F M ^a   Castro, T B R ^a   Veloso, És ^a   Queiroz, C P ^a   Ahn, J ^b   Santiago, H C ^a   Martins, F S ^a   Alves Silva, J ^a   Ferreira, E ^a   Cara, D C ^a   Vieira, A T ^a   Barber, G N ^b   Oliveira, S C ^a   Faria, A M C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; DEXTRAN SULFATE; IMMUNOGLOBULIN A; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; MEMBRANE PROTEIN; MPYS PROTEIN, MOUSE; SECRETORY IMMUNOGLOBULIN;

ALLOBACOLUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIUM; BIFIDOBACTERIUM; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOLIC SENSOR STING; DISULFOVIBRIO; FECES ANALYSIS; FOXP3 GENE; GENE FUNCTION; GOBLET CELL; HOMEOSTASIS; INFLAMMATION; INNATE LYMPHOID CELL 1; INNATE LYMPHOID CELL 2; INNATE LYMPHOID CELL 3; INTESTINAL HOMEOSTASIS; INTESTINE FUNCTION; INTESTINE PROTECTION; INTRAEPITHELIAL LYMPHOCYTE; LAP GENE; MOUSE; MUCUS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REGULATORY T LYMPHOCYTE; SPECIES COMPOSITION; T LYMPHOCYTE; TYPHOID FEVER; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; FEMALE; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE; INTESTINE FLORA; INTESTINE MUCOSA; KNOCKOUT MOUSE; LYMPHOCYTE; MALE; METABOLISM; PHYSIOLOGY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; TH1 CELL;

ANIMALS; COLITIS; DEXTRAN SULFATE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; IMMUNITY, INNATE; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; INTESTINES; LYMPHOCYTES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 85047967039     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2017.88     Document Type: Article

References (78)

1. Mayer, L. Mucosal immunity. Immunol. Rev. 206, 5 (2005).
2. Weiner, H.L., da Cunha, A.P., Quintana, F. &Wu, H. Oral tolerance. Immunol. Rev. 241, 241-259 (2011).
3. Pabst, O. &Mowat, A.M. Oral tolerance to food protein. Mucosal Immunol. 5, 232-239 (2012).
4. Honda, K. &Littman, D.R. The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 30, 759-795 (2012).
5. Hill, D.A. &Artis, D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 28, 623-667 (2010).
6. Crosnier, C., Stamataki, D. &Lewis, J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat. Rev. Genet. 7, 349-359 (2006).
7. Hu, S. et al. The DNA sensor AIM2 maintains intestinal homeostasis via regulation of epithelial antimicrobial host defense. Cell Rep. 13, 1922-1936 (2015).
8. Fukata, M. &Arditi, M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol. 6, 451-463 (2013).
9. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. &Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
10. Hu, G.Q. et al. AIM2 contributes to the maintenance of intestinal integrity via Akt and protects against Salmonella mucosal infection. Mucosal Immunol. 9, 1330-1339 (2016).
11. Ishikawa, H. &Barber, G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674-678 (2008).
12. Burdette, D.L. et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478, 515-518 (2011).
13. Sun, L., Wu, J., Du, F., Chen, X. &Chen, Z.J. Cyclic GMP-AMP synthase is a cytosolicDNAsensor that activates the type I interferon pathway. Science 339, 786-791 (2013).
14. Burdette, D.L. &Vance, R.E. STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14, 19-26 (2013).
15. Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538-550 (2008).
16. Sun, W. et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. USA 106, 8653-8658 (2009).
17. Jin, L., Waterman, P.M., Jonscher, K.R., Short, C.M., Reisdorph, N.A. &Cambier, J.C. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell Biol. 28, 5014-5026 (2008).
18. Cho, H. &Kelsall, B.L. The role of type I interferons in intestinal infection, homeostasis, and inflammation. Immunol. Rev. 260, 145-167 (2014).
19. Chirdo, F.G., Millington, O.R., Beacock-Sharp, H. &Mowat, A.M. Immunomodulatory dendritic cells in intestinal lamina propria. Eur. J. Immunol. 35, 1831-1840 (2005).
20. Kole, A. et al. Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cellmediated colitis. J. Immunol. 191, 2771-2779 (2013).
21. Sauer, J.D. et al. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79, 688-694 (2011).
22. Dobbs, N., Burnaevskiy, N., Chen, D., Gonugunta, V.K., Alto, N.M. &Yan, N. STING activation by translocation from the ER is associated with infection and autoinflammatory disease. Cell Host Microbe 18, 157-168 (2015).
23. Zhu, Q. et al. Cutting edge: STING mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation. J. Immunol. 193, 4779-4782 (2014).
24. Ahn, J., Konno, H. &Barber, G.N. Diverse roles of STINGdependent signaling on the development of cancer. Oncogene 34, 5302-5308 (2015).
25. Rudlaff, R.M. &Waters, C.M. What is the role of cyclic di-GMP signaling within the human gutmicrobiome?. Microbiome Sci. Med. 1, 39-44 (2014).
26. Danilchanka, O. &Mekalanos, J.J. Cyclic dinucleotides and the innate immune response. Cell 154, 962-970 (2013).
27. Hooper, L.V., Littman, D.R. &Macpherson, A.J. Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012).
28. Nowacki, M.R. Cell proliferation in colonic crypts of germ-free and conventional mice-preliminary report. Folia Histochem. Cytobiol. 31, 77-81 (1993).
29. Abrams, G.D., Bauer, H. &Sprinz, H. Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice. Lab. Invest. 12, 355-364 (1963).
30. Petersson, J. et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G327-G333 (2011).
31. Round, J.L. &Mazmanian, S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323 (2009).
32. Hapfelmeier, S. et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 328, 1705-1709 (2010).
33. Benveniste, J., Lespinats, G. &Salomon, J. Serum and secretory IgA in axenic and holoxenic mice. J. Immunol. 107, 1656-1662 (1971).
34. Suzuki, K. et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. USA 101, 1981-1986 (2004).
35. Fransen, F. et al. BALB/c and C57BL/6 mice differ in polyreactive IgA abundance, which impacts the generation of antigen-specific IgA and microbiota diversity. Immunity 43, 527-540 (2015).
36. Rowan, F., Docherty, N.G., Murphy, M., Murphy, B., Calvin Coffey, J. &O'Connell, P.R. Desulfovibrio bacterial species are increased in ulcerative colitis. Dis. Colon Rectum 53, 1530-1536 (2010).
37. Smith, P.M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573 (2013).
38. Ren, W. et al. Interferon Tau affects mouse intestinal microbiota and expression of IL-17. Mediat. Inflamm. 2016, 2839232 (2016).
39. Umesaki, Y., Setoyama, H.,Matsumoto, S. &Okada, Y. Expansion of alpha beta T-cell receptor-bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from thymus. Immunology 79, 32-37 (1993).
40. Cheroutre, H., Lambolez, F. &Mucida, D. The light anddark sidesof intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 11, 445-456 (2011).
41. Klose, C.S. &Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765-774 (2016).
42. Diefenbach, A., Colonna, M. &Koyasu, S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 41, 354-365 (2014).
43. Chen, M.L., Yan, B.S., Bando, Y., Kuchroo, V.K. &Weiner, H.L. Latencyassociated peptide identifies a novel CD4CD25 regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis. J. Immunol. 180, 7327-7337 (2008).
44. Bilate, A.M. &Lafaille, J.J. Induced CD4Foxp3 regulatory T cells in immune tolerance. Annu. Rev. Immunol. 30, 733-758 (2012).
45. Metidji, A., Rieder, S.A., Glass, D.D., Cremer, I., Punkosdy, G.A. &Shevach, E.M. IFN-alpha/beta receptor signaling promotes regulatory T cell development and function under stress conditions. J. Immunol. 194, 4265-4276 (2015).
46. Lee, S.E. et al. Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice. Gastroenterology 143, 145-154 (2012).
47. Kiesler, P., Fuss, I.J. &Strober, W. Experimental models of inflammatory bowel diseases. Cell. Mol. Gastroenterol. Hepatol. 1, 154-170 (2015).
48. Leach, M.W., Bean, A.G., Mauze, S., Coffman, R.L. &Powrie, F. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4 T cells. Am. J. Pathol. 148, 1503-1515 (1996).
49. Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L. &Raz, E. Tolllike receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115, 695-702 (2005).
50. Rachmilewitz, D. et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122, 1428-1441 (2002).
51. Tschurtschenthaler, M. et al. Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regeneration. Gut 63, 1921-1931 (2014).
52. Bos,N.A., Meeuwsen, C.G., Wostmann,B.S., Pleasants, J.R. &Benner, R. The influence of exogenous antigenic stimulation on the specificity repertoire of background immunoglobulin-secreting cells of different isotypes. Cell. Immunol. 112, 371-380.
53. Pabst, O., Cerovic, V. &Hornef, M. Secretory IgA in the coordination of establishment and maintenance of the microbiota. Trends Immunol. 37, 287-296 (2016).
54. Berry, D. &Reinisch,W. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases?. Best Pract. Res. Clin. Gastroenterol. 27, 47-58 (2013).
55. Dong,P.,Yang,Y.&Wang,W.P. The role of intestinal bifidobacteria onimmune system development in young rats. Early Hum. Dev. 86, 51-58 (2010).
56. Hoytema van Konijnenburg, D.P. &Mucida, D. Intraepithelial lymphocytes. Curr. Biol. 27, R737-R739 (2017).
57. Melo-Gonzalez, F. &Hepworth, M.R. Functional and phenotypic heterogeneity of group 3 innate lymphoid cells. Immunology 150, 265-275 (2017).
58. Monticelli, L.A., Osborne, L.C., Noti, M., Tran, S.V., Zaiss, D.M. &Artis, D. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc.Natl. Acad. Sci. USA 112, 10762-10767 (2015).
59. Negishi, H. et al. Essential contribution of IRF3 to intestinal homeostasis and microbiota-mediated Tslp gene induction. Proc. Natl. Acad. Sci. USA 109, 21016-21021 (2012).
60. Song, C. et al. Unique and redundant functions of NKp46 ILC3s in models of intestinal inflammation. J. Exp. Med. 212, 1869-1882 (2015).
61. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010).
62. Bernink, J.H. et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221-229 (2013).
63. Izcue, A., Coombes, J.L. &Powrie, F. Regulatory Tcells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271 (2006).
64. Sun, M., He, C., Cong, Y. &Liu, Z. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol. 8, 969-978 (2015).
65. Faria, A.M.C., Reis, B.S. &Mucida, D. Tissue adaptation: Implications for gut immunity and tolerance. J. Exp. Med. 214, 1211-1226 (2017).
66. Mowat, A.M. &Agace, W.W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14, 667-685 (2014).
67. Ishinaga, H., Takeuchi, K., Kishioka, C., Suzuki, S.,Basbaum, C. &Majima, Y. Pranlukast inhibits NF-kappaB activation and MUC2 gene expression in cultured human epithelial cells. Pharmacology 73, 89-96 (2005).
68. Ahn, D.H. et al. TNF-alpha activates MUC2 transcription via NFkappaB but inhibits via JNK activation. Cell. Physiol. Biochem. 15, 29-40 (2005).
69. Jono, H. et al. Transforming growth factor-beta-Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J. Biol. Chem. 277, 45547-45557 (2002).
70. Shan, M. et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 342, 447-453 (2013).
71. Velcich, A. et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295, 1726-1729 (2002).
72. Kranzusch, P.J., Wilson, S.C., Lee, A.S., Berger, J.M., Doudna, J.A. &Vance, R.E. Ancient origin of cGAS-STING reveals mechanism of universal 2',3' cGAMP signaling. Mol. Cell 59, 891-903 (2015).
73. Romling, U. Great times for small molecules: c-di-AMP, a second messenger candidate in Bacteria and Archaea. Sci. Signal. 1, pe39 (2008).
74. Zhang, X. et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51, 226-235 (2013).
75. de Almeida, L.A. et al. MyD88 and STING signaling pathways are required for IRF3-mediated IFN-beta induction in response to Brucella abortus infection. PLoS ONE 6, e23135 (2011).
76. Powrie, F., Leach, M.W., Mauze, S., Menon, S., Caddle, L.B. &Coffman, R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4 T cells. Immunity 1, 553-562 (1994).
77. Marino, E. et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat. Immunol. 18, 552-562 (2017).
78. Faria, A.M., Maron, R., Ficker, S.M., Slavin, A.J., Spahn, T. &Weiner, H.L. Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J. Autoimmun. 20, 135-145 (2003).